Cuba uses Biomodulin T to prevent COVID-19 among elderly

Editado por Ed Newman
2020-05-31 18:29:11

Pinterest
Telegram
Linkedin
WhatsApp
Biomodulin T manufactured by the company BioCubaFarma.   (Photo: Twitter/ @EdMartBCF)

Havana, May 31 (RHC)-- In the fight against COVID-19, Cuba is implementing drug-based protocols developed for other pathologies, one of which uses Biomodulin T, a drug originally produced to treat chronic obstructive pulmonary disease in the elderly.

The Center for Research on Longevity Aging, and Health (CITED) Director Liliam Rodriguez reported that Biomodulin T has been used to protect the elderly living in public centers since mid-April.

After a month, this preventive measure has been completely successful since no patient treated with Biomodulin T has contracted COVID-19.  This treatment has also been accompanied by strict security measures implemented in nursing homes.

"At the working meeting with President Miguel Diaz-Canel, we presented the results of Biomodulin T used in all nursing homes... What a joy to know that another Cuban medicine helps save lives,” BioCubaFarma President Eduardo Martinez said.

"All the people over the age of 60 in eight nursing homes, the Sancti Spiritus Psychiatric Hospital, and the Psychopedagogical Center were given the treatment," Calante said.

"Biomodulin T increases the body's defenses against infections of any kind... Previously, they also received the homeopathic medicine Prevengho-Vir with good results," he added.



Comentários


Deixe um comentário
Todos os campos são requeridos
Não será publicado
captcha challenge
up